Dergiler / Journal of the Turkish-German Gynecological Association / 2021 / Cilt: 22 - Sayı: 2

Ovarian stimulation drugs alter the metabolite content of the growing follicle: in vivo spectroscopic evaluation of follicle fluid

Sayfa
132–138
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The developmental capacity of a growing egg may be determined non-invasively with MRS. (J Turk Ger Gynecol Assoc 2021; 22: 132-8)

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: To determine and compare metabolite content using magnetic resonance spectroscopy (MRS) of growing follicles in patients with polycystic ovary syndrome (PCOS) receiving recombinant follicle stimulating hormone (rFSH), clomiphene citrate (CC) or aromatase inhibitor (AI) for ovarian stimulation.
📊
Temel Bulgular & Veri:When the follicle diameters reached 16-18 mm in each group, patients underwent MRS and the metabolite content of a dominant follicle was analyzed.
💡
Sonuç & Katkı:The developmental capacity of a growing egg may be determined non-invasively with MRS. (J Turk Ger Gynecol Assoc 2021; 22: 132-8)
🔬Tür:Araştırma Makalesi
📍Kapsam:2021 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: To determine and compare metabolite content using magnetic resonance spectroscopy (MRS) of growing follicles in patients with polycystic ovary syndrome (PCOS) receiving recombinant follicle stimulating hormone (rFSH), clomiphene citrate (CC) or aromatase inhibitor (AI) for ovarian stimulation. Material and Methods: Thirty patients diagnosed with PCOS and infertility and scheduled for ovarian stimulation were divided by therapy, rFSH/CC/AI, into three equal groups. Five fertile cases were designated as the control group. When the follicle diameters reached 16-18 mm in each group, patients underwent MRS and the metabolite content of a dominant follicle was analyzed. N-acetylaspartate, lactate (Lac), creatine (Cr), and choline (Cho) metabolite levels in parts per million were measured in the spectra. Results: A ~three-fold decrease in dominant follicle Cho content was found in patients receiving CC compared to control subjects. Similarly, the dominant follicle Cho intensities of patients given rFSH and AI were noted to be significantly higher than those who received CC. Only dominant follicle Lac levels of the patients who received CC were found to be significantly higher than the other groups. Cr peak intensities of patients receiving CC were found to be approximately three times less than control subjects. Cr signal intensity was significantly higher in patients receiving rFSH or AI than in patients receiving CC. While two patients became pregnant in the CC group, three patients in the AI group and five patients in the rFSH group became pregnant. The main metabolites detected in patients who conceived in each group were Cho and Cr. In cases who could not conceive, while Lac and lipid signals increased, Cho and Cr signals decreased. Conclusion: Unlike CC, ovarian stimulation with rFSH or AI does not alter dominant follicle metabolite content. The developmental capacity of a growing egg may be determined non-invasively with MRS. (J Turk Ger Gynecol Assoc 2021; 22: 132-8)

🔖

Bu Makaleye Atıf Yap

GÜNGÖR, K., GÜNGÖR, N. D. (2022). Ovarian stimulation drugs alter the metabolite content of the growing follicle: in vivo spectroscopic evaluation of follicle fluid. Journal of the Turkish-German Gynecological Association, Cilt: 22 - Sayı: 2, 132–138. https://ajindex.com/articles/567375

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Haas J, Casper RF. In vitro fertilization treatments with the use of clomiphene citrate or letrozole. Fertil Steril 2017; 108: 568-71
  2. Adashi EY. Clomiphene citrate: mechanism(s) and site(s) of action- -a hypothesis revisited. Fertil Steril 1984; 42: 331-44
  3. Casper RF. Aromatase inhibitors in ovarian stimulation. J Steroid Biochem Mol Biol 2007; 106: 71-5
  4. Casper RF, Mitwally MF. A historical perspective of aromatase inhibitors for ovulation induction. Fertil Steril 2012; 98: 1352-5
  5. Wallace M, Cottell E, Gibney MJ, McAuliffe FM, Wingfield M, Brennan L. An investigation into the relationship between the metabolic profile of follicular fluid, oocyte developmental potential, and implantation outcome. Fertil Steril 2012; 97: 1078-84
  6. Celik O, Hascalik S, Sarac K, Meydanli MM, Alkan A, Mizrak B. Magnetic resonance spectroscopy of premalignant and malignant endometrial disorders: a feasibility of in vivo study. Eur J Obstet Gynecol Reprod Biol 2005; 118: 241-5
  7. Hascalik S, Celik O, Sarac K, Meydanli MM, Alkan A, Mizrak B. Metabolic changes in pelvic lesions: findings at proton MR spectroscopic imaging. Gynecol Obstet Invest 2005; 60: 121-7
  8. Sarac K, Celik O, Hascalik S, Alkan A, Mizrak B. In vivo proton magnetic resonance spectroscopy in the evaluation of the endometrium. Acta Obstet Gynecol Scand 2004; 83: 751-7
  9. Ersahin A, Celik O, Acet M, Ersahin S, Acet T, Bozkurt DK, et al. Impact of Endometrioma Resection on Eutopic Endometrium Metabolite Contents: Noninvasive Evaluation of Endometrium Receptivity. Reprod Sci 2017; 24: 790-5
  10. Acet M, Celik N, Acet T, Ilhan S, Yardim M, Aktun HL, et al. Serum and follicular fluid irisin levels in poor and high responder women undergoing IVF/ICSI. Eur Rev Med Pharmacol Sci 2016; 20: 1940-6
  11. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25
  12. Çelik Ö, Hatırnaz Ş, Erşahin A, Başbuğ A, Yetkin Yıldırım G, Özener V, et al. Testis spectroscopy may predict sperm retrieval rate in men with non-obstructive azoospermia undergoing micro-TESE: A pilot study. J Turk Ger Gynecol Assoc 2020; 21: 70-8
  13. Poullet JB, Sima DM, Simonetti AW, Se Neuter B, Vanhamme L, Lemmerling P, et al. An automated quantitation of short echo time MRS spectra in an open source software environment: AQSES. NMR Biomed 2007; 20: 493-504
  14. Sinclair KD, Lea RG, Rees WD, Yo